since 2014, they have also been approved for obesity treatment (ref)
These likely include: Melanotan II linked to skin cancer risk and cardiovascular concerns GHRP-2 and GHRP-6 growth hormone secretagogues with more complex side effect profiles CJC-1295 associated with cardiac side effects in some reports Cathelicidin LL-37 antimicrobial peptide with limited human safety data PEG-MGF pegylated growth factor with limited clinical evidence Note that these categorisations are speculative until the FDA formally publishes its updated list
Beyond that, managing sleep, staying active, and eating regularly can all help
Functional loss and mortality in randomized clinical trials for amyotrophic lateral sclerosis: To combine, or not to Combine-That is the estimand
SeekPeptides members get access to detailed protocol libraries, community support from experienced researchers, and personalized guidance that goes far beyond what any single blog post can provide
I've been working with clinicians and patient advocates for over a decade to improve coverage for Medicare recipients for better obesity care, and this is a big step towards better access